ARWR - ARROWHEAD PHARMACEUTICALS, INC.
63.6
-1.500 -2.358%
Share volume: 2,540,475
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$65.10
-1.50
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 05-09-2024 | 08-08-2024 | 02-10-2025 | 02-10-2025 | 05-12-2025 | 08-07-2025 | 11-25-2025 | 02-05-2026 | |
| Assets | |||||||||
| Total Assets | 955.150 M | 883.759 M | 1.140 B | 1.014 B | 1.573 B | 1.381 B | 1.385 B | 1.604 B | |
| Current Assets | 541.650 M | 450.062 M | 695.471 M | 570.536 M | 1.135 B | 946.923 M | 950.639 M | 1.174 B | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 7.514 M | 4.184 M | 4.973 M | 5.735 M | 11.677 M | 13.160 M | 13.516 M | 22.855 M | |
| Short Term Investments | 395.410 M | 367.272 M | 578.276 M | 499.046 M | 911.700 M | 770.579 M | 692.818 M | 714.967 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 127.704 M | 69.399 M | 102.685 M | 53.889 M | 185.709 M | 129.793 M | 226.548 M | 201.643 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 359.252 M | 375.911 M | 386.032 M | 387.069 M | 384.803 M | 381.048 M | 382.515 M | 378.584 M | |
| Other Assets | 54.248 M | 57.786 M | 58.299 M | 56.089 M | 53.475 M | 52.641 M | 52.141 M | 51.208 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 955.150 M | 883.759 M | 1.140 B | 1.014 B | 1.573 B | 1.381 B | 1.385 B | 1.604 B | |
| Total liabilities | 459.745 M | 544.785 M | 948.739 M | 957.619 M | 889.273 M | 860.806 M | 881.879 M | 1.041 B | |
| Total current liabilities | 65.175 M | 96.714 M | 103.168 M | 93.758 M | 220.541 M | 194.530 M | 195.487 M | 347.425 M | |
| Accounts Payable | 8.521 M | 26.550 M | 11.388 M | 14.457 M | 9.980 M | 33.050 M | 17.674 M | 32.937 M | |
| Other liabilities | 280.938 M | 336.031 M | 341.361 M | 346.776 M | 352.276 M | 360.254 M | 471.509 M | 374.997 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 393.183 M | 407.789 M | 208.927 M | 200.332 M | 214.883 M | 163.108 M | |
| Other liabilities | 280.938 M | 336.031 M | 341.361 M | 346.776 M | 352.276 M | 360.254 M | 471.509 M | 374.997 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 483.794 M | 330.547 M | 185.444 M | 52.589 M | 683.321 M | 522.313 M | 466.052 M | 568.422 M | |
| Common stock | 1.769 B | 1.787 B | 1.806 B | 1.847 B | 2.107 B | 2.120 B | 2.140 B | 2.211 B | |
| Retained earnings | -1.284 B | -1.455 B | -1.626 B | -1.799 B | -1.428 B | -1.603 B | -1.627 B | -1.596 B |